Herth Hope Index (HHI)

Hope plays a crucial role in how people adapt to illness and maintain wellness. Research shows that higher levels of hope are associated with better treatment adherence, improved coping strategies, and more positive health outcomes. Unlike optimism, which is a general expectation of positive outcomes, hope involves both the motivation to achieve goals (agency) and the ability to identify pathways to reach them. The HHI captures these multiple dimensions of hope, including one’s sense of future possibilities, readiness to engage with life, and connection to others. Measuring hope helps clinicians identify patients who may benefit from hope-enhancing interventions and track whether therapeutic approaches are effectively supporting this critical psychological resource.

The HHI serves multiple clinical purposes across healthcare settings. At initial assessment, it provides a baseline measure of hope that can inform treatment planning – for instance, low scores on the interconnectedness subscale might indicate a need for interventions focusing on social support and relationships. The brief 12-item format makes it feasible for repeated administration, allowing clinicians to monitor changes in hope levels throughout treatment. Individual items can serve as conversation starters to explore specific areas where hope may be challenged. For example, if a patient strongly disagrees with “I have a sense of direction,” this opens discussion about goal-setting and future planning. The measure is particularly valuable in palliative care, chronic illness management, and rehabilitation settings where maintaining hope despite challenging circumstances is essential for quality of life.

Hope assessment is particularly valuable at key transition points in healthcare: at diagnosis of serious illness, before major medical procedures, during treatment planning, and when patients face setbacks or disease progression. Regular monitoring is also important during long-term treatment for chronic conditions, as hope levels can fluctuate with changes in symptoms, functional ability, or life circumstances. In mental health settings, assessing hope is crucial when working with depression, as hopelessness is a key risk factor for suicidal ideation. The HHI’s brevity allows for frequent monitoring without causing assessment fatigue, making it practical to track hope levels at each clinical encounter if needed. This enables early identification of declining hope, allowing for timely intervention before it significantly impacts treatment engagement or wellbeing.

When HHI scores indicate low hope, several evidence-based interventions can be implemented based on which dimensions are most affected. For low temporality/future scores, interventions might include goal-setting exercises, breaking down overwhelming goals into achievable steps, and exploring meaningful short-term objectives. For challenges with positive readiness/expectancy, cognitive interventions addressing negative thought patterns, reminiscence therapy focusing on past successes, and activities that provide mastery experiences can be helpful. When interconnectedness scores are low, interventions might focus on strengthening social connections, addressing isolation, exploring spiritual resources, or facilitating peer support groups. Hope-focused therapy approaches combine these elements, helping individuals identify and pursue personally meaningful goals while building the motivation and pathways thinking necessary to achieve them. The HHI can be administered regularly to track whether these interventions are effectively enhancing hope across its different dimensions.